FHIR IG Statistics: ValueSet/IMMZ.D.Observation
Resources that use this resource
Resources that this resource uses
| CodeSystem |
| IMMZ.D | IMMZ.D CodeSystem for Data Elements |
Narrative
Note: links and images are rebased to the (stated) source
This value set expansion contains 21 concepts.
| Code | System | Display | Definition |
| DE263 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Birth dose | Indicates if the client received a dose within 24 hours of birth. Whether a birth dose is counted as part of the primary series will depend on the antigen |
| DE203 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Completed the primary vaccination series | Indicates if the client has completed the primary vaccination series of a product/antigen. If the client has not yet completed their primary series, it means they may be expected to receive more doses to complete their vaccination regimen for the respective product/antigen |
| DE257 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Completed the booster series | Indicates if the client has completed the booster series of a product/antigen |
| DE242 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Date when primary vaccination series was completed | The date when the client completed the primary vaccination series (per product/antigen) |
| DE204 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | HIV status | The current HIV status of the client |
| DE208 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Preterm birth | The infant was preterm; the mother gave birth to the infant when gestational age was less than 37 weeks |
| DE209 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Immunocompromised | The client is known to be immunocompromised. This means the client has a weakened immune system and having a reduced ability to fight infections and other diseases |
| DE210 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Currently on ART | The client is currently receiving antiretroviral therapy (ART) |
| DE243 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Type of TB infection test performed | The type of tuberculosis (TB) infection test performed |
| DE246 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | TB infection test result | Records the result of the TB infection test |
| DE249 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Immunologically stable | The client is living with HIV and is immunologically stable with CD4 count or percentage above a minimum as defined in the HIV guidelines |
| DE250 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Clinically well | The client is living with HIV and is clinically well, as defined in HIV guidelines and WHO clinical staging |
| DE211 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Birth weight in grams | Represents the client's birth weight value measures in grams |
| DE215 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | ART start date | The date on which the client started or restarted ART |
| DE251 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | High risk of pneumococcal infection | The client is at high risk for pneumococcal infection because of underlying medical conditions (i.e. HIV infection or sickle-cell disease) |
| DE236 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Age in months when client received first meningococcal dose | The age in months when client received their first meningococcal dose |
| DE240 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | VNA level | Vaccine-induced neutralizing antibody (VNA) level, measured as a serum antibody concentration from the result of the concentrated, purified cell culture-derived and embryonated egg-based rabies vaccines (CCEEV) |
| DE253 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Risk of occupational exposure to rabies virus | Professional at risk of occupational exposure to rabies virus, particularly animal health workers. Also considered for medical professionals who regularly provide care to persons with rabies |
| DE241 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Dengue serostatus | Indicates the result of a serological test determining whether the client has antibodies against the dengue virus |
| DE201 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Contact date | The date and time of the client's contact |
| DE202 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | ANC contact number | The antenatal care (ANC) contact or visit number |
Source
{
"resourceType": "ValueSet",
"id": "IMMZ.D.Observation",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "http://smart.who.int/immunizations/ValueSet/IMMZ.D.Observation",
"version": "0.2.0",
"name": "IMMZ_D_Observation",
"title": "IMMZ.D.Observation ValueSet for Sex",
"status": "active",
"date": "2025-07-02T19:45:20+00:00",
"publisher": "WHO",
"contact": [
{
"name": "WHO",
"telecom": [
{
"system": "url",
"value": "http://who.int"
}
]
}
],
"description": "ValueSet for Observation codes for IMMZ.D",
"compose": {
"include": [
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"concept": [
{
"code": "DE263",
"display": "Birth dose"
},
{
"code": "DE203",
"display": "Completed the primary vaccination series"
},
{
"code": "DE257",
"display": "Completed the booster series"
},
{
"code": "DE242",
"display": "Date when primary vaccination series was completed"
},
{
"code": "DE204",
"display": "HIV status"
},
{
"code": "DE208",
"display": "Preterm birth"
},
{
"code": "DE209",
"display": "Immunocompromised"
},
{
"code": "DE210",
"display": "Currently on ART"
},
{
"code": "DE243",
"display": "Type of TB infection test performed"
},
{
"code": "DE246",
"display": "TB infection test result"
},
{
"code": "DE249",
"display": "Immunologically stable"
},
{
"code": "DE250",
"display": "Clinically well"
},
{
"code": "DE211",
"display": "Birth weight in grams"
},
{
"code": "DE215",
"display": "ART start date"
},
{
"code": "DE251",
"display": "High risk of pneumococcal infection"
},
{
"code": "DE236",
"display": "Age in months when client received first meningococcal dose"
},
{
"code": "DE240",
"display": "VNA level"
},
{
"code": "DE253",
"display": "Risk of occupational exposure to rabies virus"
},
{
"code": "DE241",
"display": "Dengue serostatus"
},
{
"code": "DE201",
"display": "Contact date"
},
{
"code": "DE202",
"display": "ANC contact number"
}
]
}
]
},
"expansion": {
"timestamp": "2025-06-25T16:39:07.092Z",
"contains": [
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE263",
"display": "Birth dose"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE203",
"display": "Completed the primary vaccination series"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE257",
"display": "Completed the booster series"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE242",
"display": "Date when primary vaccination series was completed"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE204",
"display": "HIV status"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE208",
"display": "Preterm birth"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE209",
"display": "Immunocompromised"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE210",
"display": "Currently on ART"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE243",
"display": "Type of TB infection test performed"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE246",
"display": "TB infection test result"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE249",
"display": "Immunologically stable"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE250",
"display": "Clinically well"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE211",
"display": "Birth weight in grams"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE215",
"display": "ART start date"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE251",
"display": "High risk of pneumococcal infection"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE236",
"display": "Age in months when client received first meningococcal dose"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE240",
"display": "VNA level"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE253",
"display": "Risk of occupational exposure to rabies virus"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE241",
"display": "Dengue serostatus"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE201",
"display": "Contact date"
},
{
"system": "http://smart.who.int/immunizations/CodeSystem/IMMZ.D",
"code": "DE202",
"display": "ANC contact number"
}
]
}
}
FHIR